Actively Recruiting

Age: 18Years - 50Years
FEMALE
ID07327775

Is the Disease Burden of Fibromyalgia Syndrome Higher in Mothers of Children With Attention-Deficit/Hyperactivity Disorder? A Prospective Controlled Study

Led by Sultan 1. Murat State Hospital · Updated on 2026-01-12

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating whether having a child diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) affects the disease burden in mothers who have Fibromyalgia Syndrome (FMS). The study will compare two groups: mothers with FMS who have children diagnosed with ADHD and mothers with FMS whose children do not have any psychiatric disorders. This observational study aims to assess differences in pain severity, quality of life, and central sensitization levels between these groups. Participants will be divided into two groups based on their children's diagnosis. The study will collect demographic data such as age, education, occupation, socioeconomic status, marital status, and number of children. Pain intensity will be measured using the Visual Analog Scale (VAS). Quality of life and functional status will be assessed with the Fibromyalgia Impact Questionnaire (FIQ), and central sensitization will be measured using the Central Sensitization Inventory (CSI). These assessments will provide baseline data for comparison. During the study, participants will provide information about their symptoms and complete questionnaires to evaluate their pain, quality of life, and central sensitization. Researchers will record symptom duration and calculate body mass index (BMI). The main outcomes measured at the start of the study include pain severity, quality of life, functional status, and central sensitization levels. The study is conducted by Sultan 1. Murat State Hospital and aims to better understand the impact of having a child with ADHD on mothers with FMS.

CONDITIONS

Brief Title

Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder

Who Can Participate

Age: 18Years - 50Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged between 18 and 50 years
  • Having one or more children aged 6 to 17 years diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD) according to DSM-5 criteria (for study group)
  • Having one or more children aged 6 to 17 years without any psychiatric disorders (for comparison group)
  • Diagnosis of Fibromyalgia Syndrome (FMS) according to 2016 American College of Rheumatology criteria
  • Being literate
Not Eligible

You will not qualify if you...

  • Receiving regular pharmacological treatment for Fibromyalgia Syndrome
  • Having an active psychiatric disorder or using psychiatric medication
  • History of infectious disease, chronic inflammatory disease, or malignancy
  • Being pregnant or breastfeeding
  • Having a central or peripheral nervous system disorder (e.g., cerebrovascular disease, multiple sclerosis)
  • Being uncooperative during clinical evaluation
  • Having comorbid conditions affecting quality of life such as congestive heart failure, chronic kidney disease, chronic liver disease, pulmonary disease, uncontrolled diabetes mellitus, or peripheral vascular disease
  • Diagnosis of hypothyroidism or hyperthyroidism
  • Having substance use disorder or alcohol use disorder

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Baseline assessment

Participants provide demographic information and undergo assessments including pain severity, quality of life, functional status, and level of central sensitization.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Sultan 1. Murat State Hospital

Edirne, Turkey (Türkiye), 22030

Actively Recruiting

Loading map...

Research Team

A

Alper Mengi, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Pilot Study of a Remote Attention-Deficit/Hyperactivity Di...

Attention-deficit/Hyperactivity Disorder

Actively Recruiting

2 locations

A Pilot Study to Evaluate the Effectiveness of Digital Thera...

Attention-Deficit/Hyperactivity Disorder

Actively Recruiting

3 locations

Study of Jornay PM (Methylphenidate Extended-Release Capsule...

Attention-deficit/Hyperactivity Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here